Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Higuchi

Showing results (211-220 of 286) with videos related to

Pageof 29
Sort By:
Anticancer Research|July 3, 2019
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively <i>via</i> Red Fluorescent Protein Labeled Stromal CellsJun Ho Park, Ming Zhao, Hiromichi Oshiro, et al.
Translational Oncology|July 14, 2020
Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survivalTakashi Higuchi, Norihiko Sugisawa, Jun Ho Park, et al.
Nature|March 29, 2013
Structural basis for the drug extrusion mechanism by a MATE multidrug transporterYoshiki Tanaka, Christopher J Hipolito, Andrés D Maturana, et al.
Anticancer Research|October 28, 2020
Structural Origin and Surgical Complications of Peripheral SchwannomasHirotaka Yonezawa, Shinji Miwa, Norio Yamamoto, et al.
Anticancer Research|August 2, 2019
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse ModelTakashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Nature|February 1, 2020
Author Correction: Structural basis for the drug extrusion mechanism by a MATE multidrug transporterYoshiki Tanaka, Christopher J Hipolito, Andrés D Maturana, et al.
Anticancer Research|January 31, 2025
Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose IvermectinSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics|October 28, 2024
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real TimeSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Biochemical and Biophysical Research Communications|December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Cancer Letters|March 15, 2019
Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse modelTakashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, et al.
Pageof 29

Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Anticancer Research|July 3, 2019
Peritoneal Metastases in a Patient-derived Orthotopic Xenograft (PDOX) Model of Colon Cancer Imaged Non-invasively <i>via</i> Red Fluorescent Protein Labeled Stromal CellsJun Ho Park, Ming Zhao, Hiromichi Oshiro, et al.
Translational Oncology|July 14, 2020
Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survivalTakashi Higuchi, Norihiko Sugisawa, Jun Ho Park, et al.
Nature|March 29, 2013
Structural basis for the drug extrusion mechanism by a MATE multidrug transporterYoshiki Tanaka, Christopher J Hipolito, Andrés D Maturana, et al.
Anticancer Research|October 28, 2020
Structural Origin and Surgical Complications of Peripheral SchwannomasHirotaka Yonezawa, Shinji Miwa, Norio Yamamoto, et al.
Anticancer Research|August 2, 2019
Sorafenib and Palbociclib Combination Regresses a Cisplatinum-resistant Osteosarcoma in a PDOX Mouse ModelTakashi Higuchi, Norihiko Sugisawa, Kentaro Miyake, et al.
Nature|February 1, 2020
Author Correction: Structural basis for the drug extrusion mechanism by a MATE multidrug transporterYoshiki Tanaka, Christopher J Hipolito, Andrés D Maturana, et al.
Anticancer Research|January 31, 2025
Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose IvermectinSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Genomics & Proteomics|October 28, 2024
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real TimeSei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Biochemical and Biophysical Research Communications|December 17, 2019
Combination of oral recombinant methioninase and decitabine arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma patient-derived orthotopic xenograft mouse modelTakashi Higuchi, Qinghong Han, Kentaro Miyake, et al.
Cancer Letters|March 15, 2019
Olaratumab combined with doxorubicin and ifosfamide overcomes individual doxorubicin and olaratumab resistance of an undifferentiated soft-tissue sarcoma in a PDOX mouse modelTakashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, et al.
Pageof 29